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(OR: 10.00 [95% CI 2.82–35.50]; p = 0.001. PAR: 16.67%), ex smoking
(OR: 2.00 [95% CI: 1.05–3.80]; p = 0.034. PAR: 21.01%), low
glomerular ﬁltration rate (GFR) (OR: 4.41 [95% CI: 1.78–10.95];
p = 0.001. PAR: 54.84%), male gender (OR: 12.08 [95% CI: 5.82–
25.08]; p = 0.001. PAR: 64.95%) and low HDL-cholesterol (OR: 10.91
[95% CI: 3.64–32.65]; p = 0.001. PAR: 76.65%). In conclusion, six
biopsychosocial predictors were associated to STEMI risk. In our
ﬁndings, the reduced levels of HDL-cholesterol and GFR are the
strongest modiﬁable predictors of STEMI in very elderly individuals,
followed by male gender, ex smoking, depressive symptoms and
current smoking.
doi:10.1016/j.bbacli.2015.05.010
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Introduction: The quality of life (QL) depends on the perception
that the person has with respect to herself. The QL of an individual
involves aspects such as: economic resources, environment,
relationships, religion, work, leisure, physical activity and physical
and mental health. For this reason, it is important that people
adopt healthy attitudes such as good nutrition and regular
physical activity, decreasing cardiovascular risk and increasing life
expectancy. Objective: To assess QL in individuals practitioners
and non-practitioners of physical activities with high or normal
Body Mass Index (BMI). Methods: This is a quantitative qualitative
study, conducted with 83 individuals of both genders, aged
between 20 and 40, students of Physical Education of the night
shift at the college “Faculdade Dom Bosco”, in the city Curitiba,
state Paraná, Brazil. All participants ﬁlled out the Short Form
questionnaire (SF-36), through which we performed the analysis
of the quality of life. Results: This study showed that the high BMI
group had a signiﬁcant limitation due to physical aspects
(p ≤ 0.02). Nevertheless, there were no differences in any of the
other dimensions measured by SF-36 (p ≥ 0.05). Conclusion:
Physical activity contributes to the QL of individuals between 20
and 40 years old with normal and high BMI, however, the high BMI
negatively impacts the daily physical activities of practitioners and
non-practitioners of physical activities, having impacts on the
cardiovascular health.
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Introduction: Elements that increase mortality, such as an
atherosclerotic burden, oxidative stress and arterial and ventricular
remodeling, commonly accompany hypertensive disease. However, a
hypertension diagnosis does not increase or may even decrease
mortality in the post myocardial infarction period, according to
previous studies. We hypothesize that the frequent prescription of
angiotensin converting enzyme (ACE) inhibitors or angiotensin II
receptor blocker (ARB) in hypertensive, as opposed to non-
hypertensive patients, would attenuate mortality in this context.
Objectives: To evaluate the impact of the ARB or ACE inhibitors use
on 30-day mortality after ST elevation myocardial infarction (STEMI)
in patients with or without hypertension diagnosis. Methods:
Consecutive STEMI patients from a prospective observational cohort
(n = 540) were followed and all-cause mortality in 30 days was
considered the primary outcome. Patients were categorized accord-
ing to ARB or ACE inhibitors previous and/or during hospitalization
use. Statistical analysis: Univariate comparisons were performed
using analysis of variance (ANOVA) and Chi-square test. Cumulative
incidence of events was evaluated by the Kaplan–Meier method and
survival curves compared by means of the log rank test. To adjust for
covariates Cox regression models were applied. Results: Consistent
with previous studies, STEMI 30-day mortality did not differ among
hypertensive and non-hypertensive patients. As expected, hyperten-
sive patients were more frequently prescribed ARB or ACE inhibitors
(p = 0.04), even after adjustment to anterior wall STEMI and to
presence of Diabetes. Hypertensive patients who did not receive ARB
nor ACE inhibitors neither before nor during hospitalization (n = 60)
had the highest percentage of the outcome (13.6%), followed by non-
hypertensive patients who did not receive neither drug (n = 98)
neither before nor during hospitalization (7%), non-hypertensive
patients who received the drugs in either moment (n = 117) (6%),
and hypertensive patients who received the drugs in either moment
(n = 263) (5.7%); (p ≤ 0.001). Conclusion: The frequent prescription
of ARB or ACE inhibitors to hypertensive patients may, at least in
part, explain the apparent reduced-mortality paradox of hyperten-
sive patients when undergoing MI.
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Purpose: The expression and activity of neuronal nitric oxide
synthase (nNOS) in central and peripheral nervous system attenuate
the sympathetic response and promote other cardioprotective effects
in animal models. However in humans those effects are uncertain. A
polymorphism at the sequence rs41279104 G/A has been associated
with a reduced expression of neuronal nitric oxide synthase.
Hypothetically, this polymorphism can inﬂuence sympathetic re-
sponsiveness, thus the clinical course and mortality of patients with
ST elevation myocardial infarction (STEMI). Therefore we investigat-
ed the impact of the A allele at rs41279104 in sympathetic activation,
endothelial function and the incidence of recurrent cardiovascular
events after STEMI. Methods: Consecutive patients were admitted in
the ﬁrst 24 h after STEMI. Blood samples and an electrocardiogram
were obtained upon ﬁrst 24 h and ﬁfth day. We assessed glycosyl-
ated hemoglobin, glucose, insulin, C-peptide and lipid proﬁle. We
genotyped rs41279104 and grouped patients according to carrier
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